BACKGROUND: Chronic pain is frequent in both hemodialysis (HD) patients and kidney transplant (KTx) recipients but its detailed characteristics have never been thoroughly investigated. AIM: To compare prevalence of pain, its locations and characteristics, and analgesics use in chronic HD and KTx patients. METHODS: A cross-sectional comparative study in 164 HD patients and 114 stable deceased donor KTx recipients. All participants completed the modified McGill Pain Questionnaire. RESULTS: Overall, 63% of HD patients and 62% of KTx patients reported pain. Fifty-four percent of HD patients and 67% of KTx patients indicated more than one location of pain. Severe pain was more common in HD patients, and prevalence of pain-associated symptoms from major body systems was higher in HD patients. Pain in both groups was mostly local, paroxysmal and/or chronic. Fifteen percent of HD patients and 37% of KTx patients with chronic pain were not receiving pain relief drugs. The general feeling of illness was lower in KTx than HD patients (4.54 ± 2.1 vs. 5.6 ± 0.7; p < 0.0001); however, in the former group, it was systematically increasing with the time after transplantation. CONCLUSIONS: A successful kidney transplantation does not lead to a significant reduction in the prevalence of pain when compared to chronic HD patients. Pain relief medications are underused in KTx patients.
BACKGROUND: Chronic pain is frequent in both hemodialysis (HD) patients and kidney transplant (KTx) recipients but its detailed characteristics have never been thoroughly investigated. AIM: To compare prevalence of pain, its locations and characteristics, and analgesics use in chronic HD and KTx patients. METHODS: A cross-sectional comparative study in 164 HDpatients and 114 stable deceased donor KTx recipients. All participants completed the modified McGill Pain Questionnaire. RESULTS: Overall, 63% of HDpatients and 62% of KTx patients reported pain. Fifty-four percent of HDpatients and 67% of KTx patients indicated more than one location of pain. Severe pain was more common in HDpatients, and prevalence of pain-associated symptoms from major body systems was higher in HDpatients. Pain in both groups was mostly local, paroxysmal and/or chronic. Fifteen percent of HDpatients and 37% of KTx patients with chronic pain were not receiving pain relief drugs. The general feeling of illness was lower in KTx than HDpatients (4.54 ± 2.1 vs. 5.6 ± 0.7; p < 0.0001); however, in the former group, it was systematically increasing with the time after transplantation. CONCLUSIONS: A successful kidney transplantation does not lead to a significant reduction in the prevalence of pain when compared to chronic HDpatients. Pain relief medications are underused in KTx patients.
Authors: Kevin C Abbott; Chyng-Wen Fwu; Paul W Eggers; Anne W Eggers; Prudence P Kline; Paul L Kimmel Journal: Transplantation Date: 2018-06 Impact factor: 4.939
Authors: Xueying Jiang; Margaret Orton; Rui Feng; Erik Hossain; Neil R Malhotra; Eric L Zager; Renyu Liu Journal: Ann Surg Date: 2017-04 Impact factor: 12.969
Authors: K L Lentine; N N Lam; A S Naik; D A Axelrod; Z Zhang; V R Dharnidharka; G P Hess; D L Segev; R Ouseph; H Randall; T Alhamad; R Devraj; R Gadi; B L Kasiske; D C Brennan; M A Schnitzler Journal: Am J Transplant Date: 2018-04-17 Impact factor: 8.086
Authors: Krista L Lentine; Ngan N Lam; Huiling Xiao; Janet E Tuttle-Newhall; David Axelrod; Daniel C Brennan; Vikas R Dharnidharka; Hui Yuan; Mustafa Nazzal; Jie Zheng; Mark A Schnitzler Journal: Am J Nephrol Date: 2015-03-27 Impact factor: 3.754
Authors: Julie H Ishida; Charles E McCulloch; Michael A Steinman; Barbara A Grimes; Kirsten L Johansen Journal: Clin J Am Soc Nephrol Date: 2018-04-19 Impact factor: 8.237
Authors: Mark B Lockwood; Jennifer L Steel; Ardith Z Doorenbos; Blanca N Contreras; Michael J Fischer Journal: Semin Nephrol Date: 2021-11 Impact factor: 5.299
Authors: Marcel Zorgdrager; Johan F M Lange; Christina Krikke; Gertrude J Nieuwenhuijs; Sybrand H Hofker; Henri G D Leuvenink; Robert A Pol Journal: World J Surg Date: 2017-02 Impact factor: 3.352